Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Apr 21 424B3 Prospectus supplement
- 11 Mar 21 424B3 Prospectus supplement
- 9 Mar 21 EFFECT Notice of effectiveness
- 5 Mar 21 POS AM Prospectus update (post-effective amendment)
- 9 Nov 20 424B3 Prospectus supplement
- 28 Sep 20 EFFECT Notice of effectiveness
- 25 Sep 20 424B3 Prospectus supplement
-
18 Sep 20 S-1/A IPO registration (amended)
- 11 Aug 20 S-1 IPO registration
CMPX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in Amendment No. 1 to the Registration Statement No. 333-244353 on Form S-1 of Compass Therapeutics, Inc. of our report dated June 23, 2020 on our audits of the consolidated financial statements of Compass Therapeutics LLC and Subsidiary as of December 31, 2019 and 2018 and for the years then ended. We also consent to the reference to our firm under the heading “Experts.”
/s/ CohnReznick LLP
Roseland, New Jersey
September 18, 2020